Market Trends of Separation Systems For Commercial Biotechnology Industry
The Biopharmaceutical Segment is Anticipated to Witness a Growth During the Forecast Period
- In the biopharmaceutical field, the separation stage is applied to remove unwanted by-products from API manufacturing, and the most used technologies are chromatography, nanofiltration, ultrafiltration, sublimation, de-sublimation, distillation, and crystallization. The biopharmaceutical segment is expected to witness significant market growth owing to the increased demand for personalized medicines and cell-based therapies and advancements in the biopharmaceutical industry.
- For instance, in November 2022, Alfa Laval launched a new multipurpose membrane filtration system that can be seamlessly connected to up and downstream operations. It increases flexibility across a range of process applications. This includes the purification of proteins, sugar, and starch, the concentration of peptides and amino acid streams, and water recovery from condensates.
- Moreover, according to the article published in September 2022 in London, identifying a molecule with therapeutic potential is the initial step in developing a medicine, after which molecules such as drug candidates are examined for metabolism and pharmacokinetics. Because of their great sensitivity and selectivity, these chemicals are routinely tested using combination techniques such as liquid chromatography-mass spectrometry (LC-MS) or LC-MS/MS.
- Also, an increase in biopharmaceutical plants across the globe is likely to increase the utilization of separation systems. For instance, in May 2022, INCOG BioPharma Services, an Indiana-based contract development and manufacturing organization (CDMO) specializing in sterile injectables, opened a biomanufacturing facility in Indiana.
- Hence, due to the increase in product launches and advancements in cell separation in biotechnology, the biopharmaceutical segment is expected to witness significant growth during the forecast period.
Understand The Key Trends Shaping This Market
Download PDF
North America Anticipated to Hold a Significant Share in the Market During the Forecast Period
- North America is expected to hold a significant market share during the forecast period due to factors such as the presence of key players, increased research activities utilizing the separation systems, and established healthcare infrastructure. Also, beneficial government initiatives and increased research partnerships are some drivers expected to increase market growth.
- For instance, as per the NIH 2022 update, the estimated research funding for biotechnology was USD 8,142 million in 2022. Hence, such high investments by the government are likely to drive market growth.
- Moreover, establishing pharmaceutical companies focusing on endocrinology is expected to boost the demand for separation systems for commercial biotechnology during the forecast period. For instance, in January 2024, Redesign Health launched healthcare startups and secured a substantial USD 4 million seed funding. Their latest venture aims to enhance diabetes care. Diabetes is a complex condition that presents challenges for both patients and puts significant stress on endocrinology practices.
- Hence, due to the increase in advancements in separation systems and the rise in research funding, North America is expected to hold a significant market share during the forecast period.
Get Analysis on Important Geographic Markets
Download PDF
